J P M O R G A N Asia Pacific Equity Research 21 November 2025 This material is neither intended to be distributed to Mainland China investors nor to provide securities investment consultancy services within the territory of Mainland China. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. China Healthcare Recent China healthcare sector weakness could mean a good setup for 2026 While we are witnessing another day of weakness in the Chi ...